Analysis

Measuring the return from pharmaceutical innovation 2014

The fifth annual study of the pharmaceutical industry’s performance in generating a return from its significant investment in R&D. The report allows industry leaders to understand the drivers of successful R&D strategies that are tangible and, most importantly, actionable.

Analysis

Medical Technology M&A

A look at medical technology macro trends and how they are making M&A more attractive than in recent years. 

Homi Kapadia

US Life Sciences Sector Leader

Homi Kapadia

1700 Market St.

Philadelphia

PA

215-246-2450

hkapadia@deloitte.com
 
 

Homi, Vice Chairman at Deloitte LLP, has 30 years of experience with life sciences, consumer business, and process industry clients. As the National Life Sciences Leader, he leads Deloitte's life sciences practice that provides audit, consulting, enterprise risk, financial advisory, and tax services to pharmaceutical, biotechnology, medical technology, and consumer health care clients. Homi has also served on the Board of Directors for Deloitte LLP and the Consulting Executive Committee.

Related topics

Connect via email

Subscribe

Submit RFP

Submit via our online form

Find an office

Find a local office

People

Matthew Hudes

Principal | U.S. Managing Principal, Biotechnology

People

Glenn Snyder

Medical Technology Segment Leader

People

Faith Glazier

Faith Glazier | Principal| Generics Segment Leader